Methyl Alcohol

Methyl Alcohol

SCHEMBL449756

CO.O.O

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABCC9ABL1ACEACHEACVR1ADORA1ADORA2AADORA2BADORA3ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALOX5ATP4AATP4BBCRBTKCACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGCRBNCUL4ACXCR1CXCR2DDB1DDCDHFRDPP4DRD2DRD3DRD4EGFRERBB2ERBB4ESR1ESR2FDPSFKBP1AFLT1FLT3FLT4GARTGHSRGRIA1GRIA2GRIA3GRIA4GRIK1GRIK2GRIK3GRIK4GRIK5GRIN2AGSK3AGSK3BHDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IDH1IDH2IMPA1ITGA2BITGB3JAK1JAK2JAK3KCNJ11KCNK3KCNK9KDRKITMEN1METMMP1MMP13MMP7MMP8NANOD2NS5bODC1OPG057OPRD1OPRK1OPRM1PPARP1PARP2PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDGFRBPIK3CAPIK3CBPIK3CDPIK3CGPIK3R1PIK3R2PIK3R3PIK3R5PKLRPPARDPPATPTGS1PTGS2RBX1ROCK1ROCK2RRM1RRM2RRM2BSCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC10A2SLC5A2SLC6A2SLC6A3SLC6A4SLC9A3SYKTACR1THRATHRBTOP1TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYK2TYMSVDRampCblablaT-3blaT-4blaT-5blaT-6blaUOE-1dacAdacBdacCfolAfolPftsIgyrAgyrBileSmecAmrcAmrcBmrdAparCparEpbp2pbp4pbpApbpFrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUthyAykgMykgO

The experimentally established mechanism targets of Methyl Alcohol. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Methyl Alcohol SCHEMBL44614 1.00
Methyl Alcohol SCHEMBL71617 1.00
Methyl Alcohol SCHEMBL9526155 1.00 TSHR (0.75)
Methyl Alcohol SCHEMBL9526147 1.00 TSHR (0.75)
Methyl Alcohol SCHEMBL449684 1.00
Methyl Alcohol SCHEMBL15348234 1.00
Methyl Alcohol SCHEMBL44615 1.00
Methyl Alcohol SCHEMBL11649435 1.00
Methyl Alcohol SCHEMBL321255 1.00 TSHR (0.75)
Methyl Alcohol SCHEMBL7862958 1.00 TSHR (0.75)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109599580-A A kind of ultra-thin membrane electrode and its preparation method and application for neat liquid fuel cell 天津理工大学 2019-04-09 CN claimed
CN-107449853-B A method of differentiating tai-chu race and Fujian-East Guangdong race Larimichthys crocea 宁波大学 2018-09-28 CN claimed
EP-3976628-B1 NEUROACTIVE STEROIDS AND COMPOSITIONS THEREOF SAGE THERAPEUTICS LLC (US) 2026-03-04 EP disclosed
US-12410210-B2 Neuroactive steroids and their methods of use SAGE THERAPEUTICS, INC. (US) 2025-09-09 US disclosed
US-20250250296-A1 NEUROACTIVE STEROIDS AND COMPOSITIONS THEREOF SAGE THERAPEUTICS, INC. 2025-08-07 US disclosed
US-20250236639-A1 NEUROACTIVE STEROIDS AND COMPOSITIONS THEREOF SAGE THERAPEUTICS, INC. 2025-07-24 US disclosed
US-20250154194-A1 NEUROACTIVE STEROIDS AND THEIR METHODS OF USE SAGE THERAPEUTICS, INC. 2025-05-15 US disclosed
US-12264177-B2 Neuroactive steroids and their methods of use SAGE THERAPEUTICS, INC. (US) 2025-04-01 US disclosed
US-12252509-B2 Neuroactive steroids and their methods of use SAGE THERAPEUTICS, INC. (US) 2025-03-18 US disclosed
US-20240343756-A1 NEUROACTIVE STEROIDS AND THEIR METHODS OF USE SAGE THERAPEUTICS, INC. 2024-10-17 US disclosed
US-20240336648-A1 NEUROACTIVE STEROIDS AND THEIR METHODS OF USE SAGE THERAPEUTICS, INC. 2024-10-10 US disclosed
US-8586545-B2 Solid materials of {[(2S, 5R,8S,11S)-5-benzyl-11-(3-guanidino-propyl)-8-isopropyl-7-methyl-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentaaza-cyclopentadec-2-yl]-acid} and methods for obtaining them MERCK PATENT GMBH (DE) 2013-11-19 US disclosed
EP-2432801-A2 NOVEL SOLID MATERIALS OF {[2S, 5R,8S,11S)-5-BENZYL-11-(3-GUANIDINO-PROPYL)-8-ISOPROPYL-7-METHYL-3,6,9,12,15-PENTAOXO-1,4,7,10,13-PENTAAZA-CYCLOPENTADEC-2-YL]-ACETIC ACID} AND METHODS FOR OBTAINING THEM Merck Patent GmbH (DE) 2012-03-28 EP disclosed
US-20120065142-A1 NOVEL SOLID MATERIALS OF AND METHODS FOR OBTAINING THEM MERCK PATENT GMBH (DE) 2012-03-15 US disclosed
WO-2010133367-A2 NOVEL SOLID MATERIALS OF {[2S, 5R,8S,11S)-5-BENZYL-11-(3-GUANIDINO-PROPYL)-8-ISOPROPYL-7-METHYL-3,6,9,12,15-PENTAOXO-1,4,7,10,13-PENTAAZA-CYCLOPENTADEC-2-YL]-ACETIC ACID} AND METHODS FOR OBTAINING THEM MERCK PATENT GMBH (DE) 2010-11-25 WO disclosed
US-5977253-A Phenolic thermosetting resins containing polyols OCCIDENTAL CHEMICAL CORPORATION (US) 1999-11-02 US disclosed
EP-0273401-B1 ISOINDOLIN-1-ONE DERIVATIVE AND ANTIARRHYTHMIC AGENT KYOWA HAKKO KOGYO KABUSHIKI KAISHA (JP) 1992-11-11 EP disclosed
US-4849441-A Isoindolin-1-one derivative and antiarrhythmic agent KYOWA HAKKO KOGYO CO., LTD. (JP) 1989-07-18 US disclosed
EP-0273401-A1 Isoindolin-1-one derivative and antiarrhythmic agent KYOWA HAKKO KOGYO KABUSHIKI KAISHA (JP) 1988-07-06 EP disclosed
US-4594424-A Mixture with a solvent and a alkali metal halide UBE INDUSTRIES, LTD. (JP) 1986-06-10 US disclosed